Skip to content
Health · Russia

The registration of the Russian vaccine in Europe is being delayed so that competitors have time to sign long-term contracts. The delays in the registration of the Russian vaccine in Europe are related to the commercial interests of those who do it. When the European agency [EMA] gives permission to use the Russian vaccine in Europe, it turns out that the market is busy, long-term contracts have been signed, the train has left for Russian companies.

Is it true?

Falseaccording to EUvsDisinfo

EUvsDisinfo checked this claim on 5 June 2021.

“disinformation”

  1. English

    Read the fact-check at EUvsDisinfo

Why it is false, according to EUvsDisinfo

  • EMA applies the same regulatory approach and scientific rigour to all vaccine applications and is in dialogue with more than 50 developers worldwide.

Summarised by Factiz from the EUvsDisinfo disproof (CC BY 4.0). Read the disproof

In a sample, we checked 292 points by hand; 3 did not fully match the source. Report an error

Around this claim

First seen
5 June 2021, aif.ru, according to EUvsDisinfo (EEAS East StratCom Task Force) · and 2 more

Where it turned up

  • Seen at aif.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 5 June 2021
  • Seen at armenia-today.ru, according to EUvsDisinfo (EEAS East StratCom Task Force), 5 June 2021
  • Seen at news.am, according to EUvsDisinfo (EEAS East StratCom Task Force), 5 June 2021

Related

NamesEuropean Medicines AgencyRussiaEurope

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: EUvsDisinfo, European External Action Service. Licence: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.

The sources are the verdict.